{
    "nctId": "NCT02257775",
    "briefTitle": "Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer",
    "officialTitle": "Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 5,
    "primaryOutcomeMeasure": "Progression rate of liver metastases",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age over 18 years.\n* First metastatic breast cancer relapse after treatment for early stage disease\n* A minimum of 10 evaluable lesions in the liver on routine x-ray CT imaging\n* Patient prescribed cytotoxic, endocrine or biological therapies\n* Patient physically and psychologically fit enough to consider sequential WB-- - DWI imaging alongside their standard disease monitoring\n* Written informed consent\n\nExclusion Criteria:\n\n* Diagnosis of other cancer within the last 5 years, other than resected non-melanoma skin cancer or cervical intraepithelial neoplasia\n* Diagnosis of brain metastases.\n* Contraindication to magnetic resonance MR imaging",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}